ICF reported a 9.4% increase in total revenue to $394.1 million, with service revenue increasing 4.1% to $275.6 million. Diluted EPS increased by 14% to $1.07, and non-GAAP EPS increased by 20% to $1.32. The company also announced the acquisition of ESAC to expand its public health technology solutions.
Total revenue increased by 9% to $394 million.
Diluted EPS increased 14% to $1.07, inclusive of $0.14 in special charges.
Non-GAAP EPS increased 20% to $1.32.
Contract awards totaled $604 million, with a trailing-twelve-month book-to-bill ratio of 1.33.
ICF increased its guidance ranges for full-year GAAP EPS to $4.05 to $4.25 and Non-GAAP EPS to $4.70 to $4.90. EBITDA is expected to be at the high end of the range or slightly above. The guidance ranges for total revenue and service revenue remain the same. Also, the company is raising its full year operating cash flow guidance to $110 million from $100 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance